🌍June 25, 2026·18h agoIndustry

eXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug Discovery

Publisher

eXoZymes

Global

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

At a glance

Publisher: eXoZymes
Region: 最新
Scope: Industry
Published: June 25, 2026

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Source route

Continue on exozymes.com

Leave the platform to read the original full article on the publisher site.

Source: eXoZymes

Scope: Industry

Open original article

Related coverage

More related coverage

Vivani Medical/2h ago

Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management

Tiziana Life Sciences/3h ago

Tiziana Announces Last Patient Successfully Dosed in its Phase 2 INFORM-MS Trial

Avacta Group/8h ago

Avacta Reports Platform-Validating Data with Faridoxorubicin during BIO International Conference